Last reviewed · How we verify

Tetanus and Diphtheria Toxoids Adsorbed For Adult Use

Sanofi Pasteur, a Sanofi Company · FDA-approved active Biologic Quality 5/100

Tetanus and Diphtheria Toxoids Adsorbed For Adult Use is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently FDA-approved. Also known as: TENIVAC.

At a glance

Generic nameTetanus and Diphtheria Toxoids Adsorbed For Adult Use
Also known asTENIVAC
SponsorSanofi Pasteur, a Sanofi Company
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tetanus and Diphtheria Toxoids Adsorbed For Adult Use

What is Tetanus and Diphtheria Toxoids Adsorbed For Adult Use?

Tetanus and Diphtheria Toxoids Adsorbed For Adult Use is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company.

Who makes Tetanus and Diphtheria Toxoids Adsorbed For Adult Use?

Tetanus and Diphtheria Toxoids Adsorbed For Adult Use is developed and marketed by Sanofi Pasteur, a Sanofi Company (see full Sanofi Pasteur, a Sanofi Company pipeline at /company/sanofi).

Is Tetanus and Diphtheria Toxoids Adsorbed For Adult Use also known as anything else?

Tetanus and Diphtheria Toxoids Adsorbed For Adult Use is also known as TENIVAC.

What development phase is Tetanus and Diphtheria Toxoids Adsorbed For Adult Use in?

Tetanus and Diphtheria Toxoids Adsorbed For Adult Use is FDA-approved (marketed).

Related